TRT may also slightly improve baseline metabolic rate, which can enhance the weight loss response to GLP-1 agents by 510% in some studies, though individual variation is substantial
Novo Nordisk found evidence of compounded drugs with impurities or no semaglutide, according to a news release in May
Although some supply constraints have eased since early shortages were declared for several GLP-1 receptor agonists, access and GLP-1 shortage concerns persist as utilization continues to outpace production in certain segments of the market
Compared to people on placebo, they found, those on semaglutide were less likely to develop heart attacks and other cardiovascular problemseven when people hadnt lost much weight at all
And are there alternative ways to achieve similar benefitsespecially using nutrition and whole-food supplements
545 For example, pelacarsen, an Lp(a) ASO drug developed by Ionis in collaboration with Novartis AG, effectively lowers Lp(a) levels by selectively cleaving Apo(a) gene (LPA) mRNA